Kobo Ofer, Levi Yaniv, Abu-Fanne Rami, Von Birgelen Clemens, Guédès Antoine, Aminian Adel, Laanmets Peep, Dewilde Willem, Witkowski Adam, Monsegu Jacques, Romo Iniguez Andres, Halabi Majdi, Mamas Mamas A, Roguin Ariel
Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
Thoraxcentrum Twente, Medisch Spectrum Twente, and Department Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Int J Cardiol Heart Vasc. 2024 Feb 26;51:101370. doi: 10.1016/j.ijcha.2024.101370. eCollection 2024 Apr.
A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs): hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs.
Patients with an indication for a PCI were stratified based upon the number of SMuRFs: 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year. Inverse weighted propensity score (IWPS) adjustment was performed to adjust for differences in baseline characteristics.
The prevalence of SMuRFs was: 0 SMuRF 16.4 %; 1 SMuRF 27.8 %; 2 SMuRFs 34.7 % and 3-4 SMuRFs 21.1 %. Patients without SMuRFs were younger, more likely to be male and had less complex coronary artery disease. The incidence of TLF increased with the number of SMuRFs: 2.65 %, 2.75 %, 3.23 %, and 4.24 %, P < 0.001. The relative risk (RR) for a TLF was 60 % higher (95 % confidence interval 1.32-1.93, p < 0.01) for patients with 3-4 SMuRFs compared to patients without SMuRFs. The trend remained (P < 0.01) after IWPS with TLF rates of 2.88 %, 2.64 %, 2.88 % and 3.65 %. The RR for a TLF was 27 % higher (95 % CI 1.05-1.53, p < 0.01).
The incidence of clinical events at 1-year increased with the number of SMuRFs. While patients without SMuRFs have a relatively favourable risk profile, more research is needed to optimize therapeutic management in the majority of patients.
接受经皮冠状动脉介入治疗(PCI)的患者中,很大一部分没有标准的可改变心血管危险因素(SMuRFs),即高血压、糖尿病、高胆固醇血症和吸烟。本分析的目的是根据SMuRFs的数量比较PCI术后的临床结局。
根据SMuRFs的数量将有PCI指征的患者分层:0个、1个、2个或3 - 4个。主要结局是靶病变失败(TLF),即1年内心脏死亡、靶血管相关心肌梗死或因临床原因导致的靶病变血运重建的复合终点。采用逆加权倾向评分(IWPS)调整来校正基线特征的差异。
SMuRFs的患病率分别为:0个SMuRFs占16.4%;1个SMuRFs占27.8%;2个SMuRFs占34.7%;3 - 4个SMuRFs占21.1%。没有SMuRFs的患者更年轻,男性比例更高,冠状动脉疾病的复杂性更低。TLF的发生率随SMuRFs数量的增加而升高:分别为2.65%、2.75%、3.23%和4.24%,P < 0.001。与没有SMuRFs的患者相比,有3 - 4个SMuRFs的患者发生TLF的相对风险(RR)高60%(95%置信区间1.32 - 1.93,p < 0.01)。IWPS调整后该趋势仍然存在(P < 0.01),TLF发生率分别为2.88%、2.64%、2.88%和